News for 'pharmaceutical investigation'

Indian drug firm recalls eye drop linked to vision loss in US

Indian drug firm recalls eye drop linked to vision loss in US

Rediff.com3 Feb 2023

Global Pharma Healthcare is recalling entire lots of eye drop linked to vision loss in the US, according to the US Food and Drug Administration. The Chennai-based company is recalling all lots of artificial tears lubricant eye drops distributed by EzriCare, LLC and Delsam Pharma to the consumer level due to possible contamination, the US health regulator said in a statement. "The Centres for Disease Control and Prevention (CDC) alerted FDA to an investigation of a multi-state cluster of Verona Integron-mediated Metallo--lactamase (VIM)- and Guiana-Extended Spectrum--Lactamase (GES)- producing carbapenem-resistant Pseudomonas aeruginosa (VIM-GES-CRPA) infections possibly associated with the use of the artificial tears manufactured by Global Pharma Healthcare," USFDA said.

Cough syrup case: Central team, UP drug dept collect 6 more samples

Cough syrup case: Central team, UP drug dept collect 6 more samples

Rediff.com30 Dec 2022

The inspection at Marion Biotech started at around 12 pm and continued for over 10 hours during which six more samples of the syrup were taken, they said.

Ashoka University founders step down from board after CBI probe

Ashoka University founders step down from board after CBI probe

Rediff.com7 Jan 2022

Ashoka University co-founders Vineet Gupta and Pranav Gupta, who were booked last week by the Central Bureau of Investigation in a Rs 1,600 crore fraud case, on Thursday stepped down from all boards and committees of the varsity.

Uzbek kids' death: Noida company loses manufacturing licence

Uzbek kids' death: Noida company loses manufacturing licence

Rediff.com23 Mar 2023

The manufacturing licence of Noida-based pharmaceutical firm Marion Biotech has been cancelled by the Uttar Pradesh authorities, according to officials.

Central panel to study WHO report on deaths linked to Indian syrups

Central panel to study WHO report on deaths linked to Indian syrups

Rediff.com12 Oct 2022

They said after examining and analysing the adverse event reports, causal relationship and all related details shared by or to be shared by the WHO, the committee will advise and recommend further course of action to the Drugs Controller General of India (DCGI).

Cough syrup deaths: DCGI bans use of propylene glycol supplied by Delhi firm

Cough syrup deaths: DCGI bans use of propylene glycol supplied by Delhi firm

Rediff.com11 Mar 2023

Maya Chemtech India Pvt Ltd supplied propylene glycol used in Marion Biotech's cough syrups that were found to be "not of standard quality", according to the regulator.

First nasal spray for treating Covid patients launched in India

First nasal spray for treating Covid patients launched in India

Rediff.com9 Feb 2022

The company claims that when the Nitric Oxide Nasal is sprayed over nasal mucosa it acts as a physical and chemical barrier against the virus.

3 employees of Noida pharma arrested in Uzbek cough syrup death case

3 employees of Noida pharma arrested in Uzbek cough syrup death case

Rediff.com3 Mar 2023

Three employees of a Noida-based pharmaceutical firm, whose cough syrup is alleged to have led to the death of 18 children in Uzbekistan last year, were arrested on charges of manufacturing and sale of adulterated drugs, officials said.

Bharat Biotech cancels Covaxin deals with Brazil firms after graft row

Bharat Biotech cancels Covaxin deals with Brazil firms after graft row

Rediff.com23 Jul 2021

The termination of the MoU came after the deal with the Brazilian government for supply of 20 million doses of the vaccine landed in controversy and attracted investigation by authorities in that country.

Kashmir University PhD scholar held for seditious magazine article

Kashmir University PhD scholar held for seditious magazine article

Rediff.com17 Apr 2022

Abdul Aala Fazili was arrested from his Humhama residence as the SIA conducted searches at several locations in the city as part of its crackdown on terror and anti-national networks, the official said.

50 million doses of Covaxin set to expire in 2023

50 million doses of Covaxin set to expire in 2023

Rediff.com6 Nov 2022

Nearly 50 million doses of Bharat Biotech's COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers owing to poor demand, company sources said.

Ethical Code to keep doctor, drugmaker nexus at bay not mandatory yet

Ethical Code to keep doctor, drugmaker nexus at bay not mandatory yet

Rediff.com22 Aug 2022

'Gift-giving' - from free dinners and drug samples to promotional merchandise - seems to be driving drugmakers' marketing - a marketing prescription deeply entrenched in the industry. This is a well-oiled racket that sees pharmaceutical (pharma) companies 'gifting' doctors to push their respective drugs under the guise of marketing. But is there a cure in sight to end this unhealthy alliance? The recent controversy following the income-tax raids on Bengaluru-based drugmaker Micro Labs, makers of popular paracetamol brand Dolo-650, has brought this to the fore, again.

Merck to license oral Covid drug Molnupiravir to 5 Indian firms

Merck to license oral Covid drug Molnupiravir to 5 Indian firms

Rediff.com27 Apr 2021

Drug firm MSD has decided to enter into voluntary licensing agreements for investigational oral antiviral drug candidate 'Mmolnupiravir', which is being studied for the treatment of Covid-19, with Indian drug firms Sun Pharma, Cipla, Dr Reddy's, Emcure Pharma and Hetero Labs, its Indian arm said on Tuesday.

6 workers killed in fire in chemical factory in AP

6 workers killed in fire in chemical factory in AP

Rediff.com14 Apr 2022

More than 50 workers were at work in the night shift when the mishap occurred in unit-4.

Amid rise in Covid cases, Centre prohibits exports of Remdesivir

Amid rise in Covid cases, Centre prohibits exports of Remdesivir

Rediff.com11 Apr 2021

Remdesivir is considered a key anti-viral drug in the fight against Covid-19. In addition, the government has taken three steps to ensure easy access of hospitals and patients to Remdesivir.

Ahmed Patel's son-in-law, Dino Morea's assets seized in PMLA case

Ahmed Patel's son-in-law, Dino Morea's assets seized in PMLA case

Rediff.com2 Jul 2021

The Enforcement Directorate has alleged that this is a bigger bank scam in volume than that of the Punjab National Bank fraud by fugitive diamantaires Nirav Modi and Mehul Choksi, as it involves fraud to the tune of about Rs 16,000 crore.

'Worse for heart attacks': British Indian doc flags issues with Covishield

'Worse for heart attacks': British Indian doc flags issues with Covishield

Rediff.com7 Feb 2023

Dr Malhotra, who has demanded a full safety review into the use of AstraZeneca's Covid vaccine, told PTI Covishield "should never have been rolled out in the country in the first place".

Brazil scraps Covaxin's EUA application

Brazil scraps Covaxin's EUA application

Rediff.com27 Jul 2021

The Brazilian health regulator's decision comes after the vaccine maker informed the South American country about the termination of its pact with its partners in that country.

Court rejects Mamta Kulkarni's plea to de-freeze bank accounts

Court rejects Mamta Kulkarni's plea to de-freeze bank accounts

Rediff.com3 Aug 2021

On April 14, 2016, the crime branch of the Thane police had seized over 20 tonnes of ephedrine and 2.5 tonnes of acetic anhydride drugs from a pharmaceutical factory - Avon Life Sciences - in Solapur and other locations in Thane and Ahmedabad.

GSK withdraws sale of Zinetac after health alert

GSK withdraws sale of Zinetac after health alert

Rediff.com26 Sep 2019

GSK is continuing with investigations into the potential source of the NDMA, which is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables.

Covishield booster works against Omicron

Covishield booster works against Omicron

Rediff.com24 Dec 2021

If the vaccine is recommended for use as a booster against Omicron, it may significantly boost the demand for Covishield in India.

Brazil suspends Bharat Biotech's Covaxin clinical trials

Brazil suspends Bharat Biotech's Covaxin clinical trials

Rediff.com24 Jul 2021

The termination of the pact comes after the deal with the Brazilian government for supply of 20 million doses of the vaccine landed in controversy and attracted investigation by authorities in that country.

2 workers die, 26 injured in fire at UPL chemical plant in Gujarat

2 workers die, 26 injured in fire at UPL chemical plant in Gujarat

Rediff.com23 Feb 2021

The fire broke out after a blast at United Phosphorus Ltd's plant in Jhagadia GIDC industrial area, said inspector P H Vasava of the local police station.

Trade margins capped at 70% for oximeters, BP meters, other medical devices

Trade margins capped at 70% for oximeters, BP meters, other medical devices

Rediff.com14 Jul 2021

The medical devices, which have been in high demand during the Covid-19 pandemic, will now see a drop in prices, as the earlier margins were up to 709 per cent for some of these products.

Why Doctors Stopped Being Gods

Why Doctors Stopped Being Gods

Rediff.com15 Sep 2022

I got to know that every referred case for angiography and angioplasty got a kickback of Rs 5,000 and Rs 15,000 respectively. Seeing this trend, doctors started paying referring doctors Rs 1 lakh in advance and adjusting it as and when patients came in. This menace slowly spread its tentacles all over the medical field, including radiological diagnostics and biochemistry laboratories. For every test ordered, 20 per cent of the bill was given back to the referring doctor. This led to doctors recommending unnecessary tests. The pharmaceutical companies also saw burgeoning business. Acclaimed doctors were given televisions sets, refrigerators, air conditioners and cars depending upon the prescriptions. General practitioners would prescribe unnecessary drugs, and were given returns in cash. A fascinating excerpt from Dr Upendra Kaul's When The Heart Speaks.

Data leak shows massive infiltration by China's Communist Party

Data leak shows massive infiltration by China's Communist Party

Rediff.com14 Dec 2020

The data leak obtained by 'The Australian' newspaper has revealed how the alleged CPC members are employed with some of the world's biggest corporations in the areas of defence, banks and pharmaceutical giants manufacturing coronavirus vaccines.

Ranbaxy may have to pay huge fine, again

Ranbaxy may have to pay huge fine, again

Rediff.com14 Apr 2014

Last year, Ranbaxy had to pay a fine of $500 million to the US authorities after it pleaded guilty to fraudulent activities and misrepresenting data to seek fast approvals.

Cadila launches Remdesivir in India at Rs 2,800 per vial

Cadila launches Remdesivir in India at Rs 2,800 per vial

Rediff.com13 Aug 2020

The company said the drug will be made available across India through the group's strong distribution chain reaching out to government and private hospitals treating COVID-19 patients.

More Covid vaccine candidates get approval for clinical trials in India

More Covid vaccine candidates get approval for clinical trials in India

Rediff.com6 Feb 2021

Ahmedabad-based Zydus Cadila, Bharat Biotech's intra-nasal candidate are among the candidates who got approval from the expert panel to conduct clinical trials, Sohini Das reports.

3 Indian pharma firms named in US Congress price probe

3 Indian pharma firms named in US Congress price probe

Rediff.com9 Oct 2014

Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months

Glenmark initiates studies to develop new molecule

Glenmark initiates studies to develop new molecule

Rediff.com4 Feb 2013

It can possibly be used to treat diseases like Arthritis and bowel disease.

US drug regulator warns RPG Life Sciences

US drug regulator warns RPG Life Sciences

Rediff.com19 Jun 2013

The US Food and Drug Administration (USFDA) has issued a warning letter to RPG Life Sciences for violation of current good manufacturing practice (CGMP) norms at its two plants at Ankleshwar and Mumbai.

Pfizer withdraws emergency use for its Covid vaccine in India

Pfizer withdraws emergency use for its Covid vaccine in India

Rediff.com5 Feb 2021

An expert panel of the country's drugs regulatory authority had recommended against granting such approval to the firm at this stage just two days ago, officials said.

The bizarre tale of Cairn retro tax

The bizarre tale of Cairn retro tax

Rediff.com6 Mar 2022

The levy of retrospective tax on the UK's Cairn Energy Plc is a tale of bizarre twists and turns that saw its attached shares being sold in May 2018 amid the passing of the baton from a full-time finance minister to interim one and the talks at the highest level to resolve the dispute, to claims that levy of back taxes was a result of an investigation into Panama Papers leak. The government late last month refunded about Rs 7,900 crore it had collected from selling residual shares of the British firm in its erstwhile India unit, seizing dividend and withholding tax refunds, to settle an eight-year-old dispute that had tarred the country's reputation as an investment destination. But, this did not come about easily. For seven years, the establishment vehemently justified in courts and outside seeking of Rs 10,247 crore in back taxes plus interest and penalty from a firm that gave India its biggest onshore oil discovery.

Police apprehend 2 men carrying Rs 27 lakh new notes

Police apprehend 2 men carrying Rs 27 lakh new notes

Rediff.com24 Nov 2016

On a tip-off from intelligence agencies, the Crime Branch team apprehended Ajit Pal Singh and Rajender Singh on Thursday evening, said a senior police officer.

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

Rediff.com21 Oct 2014

On October 2, a legislature committee wrote letters to the 14 companies, initiating an investigation and seeking details about recent price increases in several generic products available in the American market.

COVID-19: Remdesivir will be available from next week

COVID-19: Remdesivir will be available from next week

Rediff.com4 May 2020

The EUA allows for Remdesivir to be distributed in the US and administered intravenously by health care providers, as appropriate, to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalised with severe condition.

India-US coalition begin clinical trials for coronavirus

India-US coalition begin clinical trials for coronavirus

Rediff.com17 Mar 2020

The trial began at the Kaiser Permanente Washington Health Research Institute in Seattle as the first participant received the investigational vaccine.

Gas leak at pharma plant in Vizag leaves 2 dead

Gas leak at pharma plant in Vizag leaves 2 dead

Rediff.com30 Jun 2020

The leakage of benzimidazole gas occurred at Sainor Life Sciences Pvt Ltd in Visakhapatnam on Monday night.

COVID-19 vaccines likely to have longer shelf life

COVID-19 vaccines likely to have longer shelf life

Rediff.com14 Dec 2020

A longer shelf life is critical, given many makers have started manufacturing vaccines and stockpiling them, so as to make them available in the market immediately after approval, reports Sohini Das.